APA (7th ed.) Citation

Carlos Cuesta-Mateos, Raquel Juárez-Sánchez, Tamara Mateu-Albero, Javier Loscertales, Wim Mol, Fernando Terrón, & Cecilia Muñoz-Calleja. (2021). Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: The paradigm of CLL. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Carlos Cuesta-Mateos, Raquel Juárez-Sánchez, Tamara Mateu-Albero, Javier Loscertales, Wim Mol, Fernando Terrón, and Cecilia Muñoz-Calleja. Targeting Cancer Homing into the Lymph Node with a Novel Anti-CCR7 Therapeutic Antibody: The Paradigm of CLL. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Carlos Cuesta-Mateos, et al. Targeting Cancer Homing into the Lymph Node with a Novel Anti-CCR7 Therapeutic Antibody: The Paradigm of CLL. Taylor & Francis Group, 2021.